Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Moore John R sold 5,016 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Moore John R (General Counsel) sold 5,016 Edgewise Therapeutics, Inc. shares at an average US$43.83 for US$220K, leaving 17,697 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 5,016 shares
- Price
- US$43.83 average (US$43.80 to US$44.50)
- Value
- US$220K
- Holding after
- 17,697 shares
- Trading plan
- No
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 5,781 | 15,995 | Direct | |
| Aug 12, 2026 | Common Stock | Option exercise | 6,718 | 22,713 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 2,439 | US$43.81 | 20,274 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 59 | US$44.41 | 20,215 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 99 | US$44.50 | 20,116 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 2,419 | US$43.80 | 17,697 | Direct |